From pure FPP to mixed FPP and CAAX competitive inhibitors of farnesyl protein transferase

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 8, 2003, Pages 1459-1462

  Lannuzel, Marc ^a   Lamothe, Marie ^a   Schambel, Philippe ^a   Etiévant, Chantal ^a   Hill, Bridget ^a   Perez, Michel ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FARNESYL DIPHOSPHATE; PROTEIN FARNESYLTRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR;

AMINATION; ARTICLE; CELL ACTIVITY; CELL ASSAY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING SITE; DRUG INHIBITION; DRUG SYNTHESIS; DRUG TRANSFORMATION; ENZYME ISOLATION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE H RAS; RAT; SAPONIFICATION;

EID: 0037451827     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00171-9     Document Type: Article

References (25)

1. Cox A.D., Der C.J. Curr. Opin. Pharmacol. 2:2002;388.
2. Barbacid M. Annu. Rev. Biochem. 56:1987;779.
3. Prendergast G.C., Rane N. Expert Opin. Investig. Drugs. 10:2001;2105.
4. Ashar H.R., James L., Gray K., Carr D., Black S., Armstrong L., Bishop W.R., Kirschmeier P. J. Biol. Chem. 275:2000;30451.
5. Gibbs R.A., Zahn T.J., Sebolt-Leopold J.S. Curr. Med. Chem. 8:2001;1437.
6. Lamothe M., Perrin D., Blotières D., Leborgne M., Gras S., Bonnet D., Hill B.T., Halazy S. Bioorg. Med. Chem. Lett. 6:1996;1291.
7. Starrett E.J., Tortolani D.R., Russell J., Hitchcock M.J.M., Whiterock V., Martin J.C., Mansuri M.M. J. Med. Chem. 37:1994;1857.
8. Benzaria S., Pélicano H., Johnson R., Maury G., Imbach J.-L., Aubertin A.-M., Obert G., Gosselin G. J. Med. Chem. 39:1996;4958.
9. Gibbs J.B., Pompliano D.L., Mosser S.D., Rands E., Lingham R.B., Singh S.B., Scolnick E.M., Kohl N.E., Oliff A. J. Biol. Chem. 268:1993;7617.
10. (a) Dunten P., Kammlott U., Crowther R., Weber D., Palermo R., Birktoft J. Biochemistry. 37:1998;7907 (b) Long S.B., Casey P.J., Beese L.S. Biochemistry. 37:1998;9612.
11. (a) Dunten P., Kammlott U., Crowther R., Weber D., Palermo R., Birktoft J. Biochemistry. 37:1998;7907 (b) Long S.B., Casey P.J., Beese L.S. Biochemistry. 37:1998;9612.
12. Daninos-Zeghal S., Mourabit A.A., Ahond A., Poupat C., Potier P. Tetrahedron. 53:1997;7605.
13. Dinsmore C.J., Williams T.M., O'Neill T.J., Liu D., Rands E., Culberson J.C., Lobell R.B., Koblan K.S., Kohl N.E., Gibbs J.B. Bioorg. Med. Chem. Lett. 9:1999;3301.
14. Fmoc-Phe-Wang was purchased from Senn Chemical (Dielsdorf Switzerland).
15. Lamothe M., Lannuzel M., Perez M. J. Comb. Chem. 4:2002;73.
16. Pompliano D.L., Gomez R.P., Anthony N.J. J. Am. Chem. Soc. 114:1992;7945.
17. FlexX version 1.11 part of SYBYL molecular modeling software from Tripos Inc.
18. (a) Long S.B., Hancock P.J., Kral A.M., Hellinga H.W., Beese L.S. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12948
19. (b) Bell I.M., Gallicchio S.N., Abrams M., Beese L.S., Beshore D.C., Bhimnathwala H., Bogusky M.J., Carolyn A., Culberson J.C., Davide J., Ellis H., Fernandes C., Gibbs J.B., Graham S.L., Hamilton K.A., Hartman G.D., Heimbrook D.C., Homnick C., Huber H.E., Huff J.R., Kassahun K., Koblan K.S., Nancy E., Lobell R.B., Lynch J.J. Jr., Robinson R., Rodrigues A.D., Taylor J.S., Walsh E.S., Williams T.M., Zartman C.B. J. Med. Chem. 45:2002;2388.
20. Schlitzer M. Curr. Pharm. Des. 8:2002;1713.
21. (a) Moreno Barber A., Hardcastle I.R., Rowlands M.G., Nutley B.P., Marriott J.H., Jarman M. Bioorg. Med. Chem. Lett. 9:1999;623
22. (b) Schlitzer M., Satter I. Bioorg. Med. Chem. 7:1999;2391
23. (c) Chehade K.A.H., Andres D.A., Morimoto H., Spielmann H.P. J. Org. Chem. 65:2000;3027
24. (d) Turek T.C., Gaon I., Distefano M.D. J. Org. Chem. 66:2001;3253
25. (e) Zhou C., Shao Y., Gibbs R.A. Bioorg. Med. Chem. Lett. 12:2002;1417.